What question did this study set out to answer?

To explore the feasibility and outcomes of performing transcatheter mitral valve-in-valve through a residual iatrogenic atrial septal defect.

April 20, 2026Open Access

Transseptal Mitral Valve-in-Valve via a Residual Iatrogenic ASD: How We Did It

Key Points

To explore the feasibility and outcomes of performing transcatheter mitral valve-in-valve through a residual iatrogenic atrial septal defect.
Described the procedural approach for transseptal mitral valve-in-valve using a residual atrial septal defect.

Structured PICO

Population

Patients with degenerated surgical mitral bioprostheses and residual iatrogenic atrial septal defects (ASDs)

Intervention

Transseptal transcatheter mitral valve-in-valve (MViV) via a residual iatrogenic ASD

Describes a procedural strategy for performing transseptal mitral valve-in-valve utilizing a residual iatrogenic atrial septal defect.

Abstract

Degenerated surgical mitral bioprostheses may require reintervention, and transcatheter mitral valve-in-valve (MViV) has emerged as a less invasive alternative. Residual iatrogenic atrial septal defects (ASDs) may complicate hemodynamics but can also be incorporated into procedural strategy.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Weili Liu

Dacheng Li

Yan Xu

Journals

JACC Case Reports

Actions

Institutions

Qingdao University

Affiliated Hospital of Qingdao University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Transseptal Mitral Valve-in-Valve via a Residual Iatrogenic ASD: How We Did It

Key Points

Structured PICO

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study